Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Anemia with Excess Blasts
• Chronic Myeloid Leukemia
• Essential Thrombocythemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia
• Polycythemia Vera

Drugs mentioned

• Biological therapy

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1, Phase 2 | Status: COMPLETED